Kontigo Care AB (publ) (KONT.ST)
SEK 2.64
(-1.49%)
SEK 2.64
(-1.49%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 43.23 Million SEK | -89.37% |
| 2022 | 25.33 Million SEK | 0.29% |
| 2021 | 25.26 Million SEK | 19.63% |
| 2020 | 21.11 Million SEK | 13.53% |
| 2019 | 18.6 Million SEK | -5.7% |
| 2018 | 19.72 Million SEK | -1.64% |
| 2017 | 20.05 Million SEK | -0.94% |
| 2016 | 20.24 Million SEK | 412.85% |
| 2015 | 3.94 Million SEK | -39.63% |
| 2014 | 6.53 Million SEK | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 10.42 Million SEK | -5.38% |
| 2024 Q2 | 9.03 Million SEK | -13.25% |
| 2023 Q3 | 5.4 Million SEK | -48.25% |
| 2023 Q4 | 11.01 Million SEK | 103.79% |
| 2023 FY | 2.69 Million SEK | -89.37% |
| 2023 Q1 | 7.46 Million SEK | 8.42% |
| 2023 Q2 | 10.44 Million SEK | 39.88% |
| 2022 Q3 | 5.79 Million SEK | -5.25% |
| 2022 FY | 25.33 Million SEK | 0.29% |
| 2022 Q2 | 6.11 Million SEK | -6.53% |
| 2022 Q1 | 6.54 Million SEK | -4.68% |
| 2022 Q4 | 6.88 Million SEK | 18.81% |
| 2021 Q3 | 5.87 Million SEK | -9.82% |
| 2021 FY | 25.26 Million SEK | 19.63% |
| 2021 Q1 | 6 Million SEK | 4.48% |
| 2021 Q2 | 6.51 Million SEK | 8.56% |
| 2021 Q4 | 6.86 Million SEK | 16.78% |
| 2020 Q4 | 5.74 Million SEK | 14.73% |
| 2020 Q3 | 5 Million SEK | -7.29% |
| 2020 FY | 21.11 Million SEK | 13.53% |
| 2020 Q2 | 5.4 Million SEK | 8.91% |
| 2020 Q1 | 4.96 Million SEK | 16.81% |
| 2019 FY | 18.6 Million SEK | -5.7% |
| 2019 Q3 | 4.56 Million SEK | -8.97% |
| 2019 Q4 | 4.24 Million SEK | -7.05% |
| 2019 Q2 | 5.01 Million SEK | 5.2% |
| 2019 Q1 | 4.77 Million SEK | -3.75% |
| 2018 Q4 | 4.95 Million SEK | 17.27% |
| 2018 Q3 | 4.22 Million SEK | -18.95% |
| 2018 Q1 | 5.33 Million SEK | 37.34% |
| 2018 Q2 | 5.21 Million SEK | -2.16% |
| 2018 FY | 19.72 Million SEK | -1.64% |
| 2017 Q2 | 5.6 Million SEK | 13.48% |
| 2017 FY | 20.05 Million SEK | -0.94% |
| 2017 Q4 | 3.88 Million SEK | -13.97% |
| 2017 Q1 | 4.94 Million SEK | -0.46% |
| 2017 Q3 | 4.51 Million SEK | -19.53% |
| 2016 Q1 | 5.12 Million SEK | 133.11% |
| 2016 Q4 | 4.96 Million SEK | 25.39% |
| 2016 Q2 | 6.2 Million SEK | 20.97% |
| 2016 FY | 20.24 Million SEK | 412.85% |
| 2016 Q3 | 3.95 Million SEK | -36.17% |
| 2015 FY | 3.94 Million SEK | -39.63% |
| 2015 Q4 | -15.47 Million SEK | -415.92% |
| 2015 Q1 | 6.01 Million SEK | 91.03% |
| 2015 Q2 | 8.5 Million SEK | 41.37% |
| 2015 Q3 | 4.9 Million SEK | -42.41% |
| 2014 Q4 | 3.15 Million SEK | 95.21% |
| 2014 Q1 | 887 Thousand SEK | 0.0% |
| 2014 FY | 6.53 Million SEK | 0.0% |
| 2014 Q3 | 1.61 Million SEK | -7.45% |
| 2014 Q2 | 1.74 Million SEK | 96.62% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Aino Health AB (publ) | 13.31 Million SEK | -224.777% |
| Bonzun AB (publ) | 5.00 SEK | -864619900.0% |
| Medhelp Care Aktiebolag (publ) | 100.87 Million SEK | 57.142% |
| RaySearch Laboratories AB (publ) | 800.7 Million SEK | 94.601% |
| Surgical Science Sweden AB (publ) | 367.6 Million SEK | 88.24% |